FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1945269077> ?p ?o ?g. }

• W1945269077 abstract "We thank our colleagues for their response, confirming that tailored treatment in rheumatoid arthritis patients is an important topic to address [1]. Current guidelines promote the use of prognostic factors in treatment decisions [2], but perspectives on the predicted outcome vary. Although current treatment strategies suppress radiographic progression in most patients, rapid clinical improvement (RCI) remains relevant for functional restoration [3]. We aimed to predict RCI in patients with a poor prognosis (PP) and with a nonpoor prognosis (non-PP). We based classification on prognostic factors mentioned in the European League Against Rheumatism recommendations (method 1) [2] and, for confirmation, on the Visser model (method 2), despite its focus on predicting rapid radiographic progression (RRP) [4]. We did not aim to compare both methods for superiority, but as our colleagues propose this approach we need to reiterate some of the numbers to accomplish accurate interpretation of our results.First, of the PP patients following Visser’s model (defined as having >50 % RRP risk) receiving initial monotherapy (iMono), 46 % (not 64 %, as our colleagues mention) in fact developed RRP (Table S1 in [5]). As concluded previously, this model predicts RRP better than method 1, in which 26 % of PP patients developed RRP. However, we were interested in predicting RCI.Second, the separation in the Health Assessment Questionnaire for PP patients versus non-PP patients treated with initial combination therapy (iCombo) (Figure S1 in [5]) is 0.11 to 0.13 per time point; that is, not clinically relevant differences [6]. However, relevant differences in the Health Assessment Questionnaire were shown after 3 months, when comparing iMono with iCombo both in PP and in non-PP patients using methods 1 and 2 (Table S1 in [5]).Last, our colleagues attempt to compare both methods for predicting American College of Rheumatology 20/50/70 response on iCombo or on iMono in PP patients and non-PP patients. However, all odds ratios listed were determined with Visser’s method. Odds ratios determined using method 1 (Table 1) were not published previously. Comparing methods 1 and 2, the 95 % confidence intervals are largely overlapping, making it impossible to conclude that one method is superior in predicting American College of Rheumatology response without advanced statistics. These results indicate that, regardless of the method, both PP patients and non-PP patients benefit from iCombo, achieving RCI (Table 1).Table 1Odds ratios for achieving ACR response after 3 months for patients treated with initial combination therapy compared with initial monotherapyWe maintain that with currently known predictors it is still impossible to define a subgroup that will achieve equal RCI on iMono as that on iCombo. Future research may reveal prognostic factors enabling us to stratify patients for differential treatment. In the meantime, more patients achieve RCI on iCombo than on iMono. This may constitute overtreatment if aiming to prevent future radiographic damage, but prevents undertreatment of debilitating arthritis already present." @default.
• W1945269077 created "2016-06-24" @default.
• W1945269077 creator A5015727845 @default.
• W1945269077 creator A5052842332 @default.
• W1945269077 creator A5075695885 @default.
• W1945269077 creator A5087578278 @default.
• W1945269077 date "2015-07-02" @default.
• W1945269077 modified "2023-10-07" @default.
• W1945269077 title "Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply" @default.
• W1945269077 cites W1708410594 @default.
• W1945269077 cites W2046210313 @default.
• W1945269077 cites W2120393706 @default.
• W1945269077 cites W2142221607 @default.
• W1945269077 cites W2142279201 @default.
• W1945269077 cites W2169772272 @default.
• W1945269077 cites W4210768724 @default.
• W1945269077 doi "https://doi.org/10.1186/s13075-015-0681-7" @default.
• W1945269077 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4488129" @default.
• W1945269077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26135890" @default.
• W1945269077 hasPublicationYear "2015" @default.
• W1945269077 type Work @default.
• W1945269077 sameAs 1945269077 @default.
• W1945269077 citedByCount "0" @default.
• W1945269077 crossrefType "journal-article" @default.
• W1945269077 hasAuthorship W1945269077A5015727845 @default.
• W1945269077 hasAuthorship W1945269077A5052842332 @default.
• W1945269077 hasAuthorship W1945269077A5075695885 @default.
• W1945269077 hasAuthorship W1945269077A5087578278 @default.
• W1945269077 hasBestOaLocation W19452690771 @default.
• W1945269077 hasConcept C126322002 @default.
• W1945269077 hasConcept C1862650 @default.
• W1945269077 hasConcept C198451711 @default.
• W1945269077 hasConcept C2777489490 @default.
• W1945269077 hasConcept C2777575956 @default.
• W1945269077 hasConcept C3020404979 @default.
• W1945269077 hasConcept C71924100 @default.
• W1945269077 hasConceptScore W1945269077C126322002 @default.
• W1945269077 hasConceptScore W1945269077C1862650 @default.
• W1945269077 hasConceptScore W1945269077C198451711 @default.
• W1945269077 hasConceptScore W1945269077C2777489490 @default.
• W1945269077 hasConceptScore W1945269077C2777575956 @default.
• W1945269077 hasConceptScore W1945269077C3020404979 @default.
• W1945269077 hasConceptScore W1945269077C71924100 @default.
• W1945269077 hasLocation W19452690771 @default.
• W1945269077 hasLocation W19452690772 @default.
• W1945269077 hasLocation W19452690773 @default.
• W1945269077 hasLocation W19452690774 @default.
• W1945269077 hasOpenAccess W1945269077 @default.
• W1945269077 hasPrimaryLocation W19452690771 @default.
• W1945269077 hasRelatedWork W1708410594 @default.
• W1945269077 hasRelatedWork W1801878747 @default.
• W1945269077 hasRelatedWork W1964540377 @default.
• W1945269077 hasRelatedWork W1982831126 @default.
• W1945269077 hasRelatedWork W1982847998 @default.
• W1945269077 hasRelatedWork W2018679211 @default.
• W1945269077 hasRelatedWork W2022169582 @default.
• W1945269077 hasRelatedWork W2023079206 @default.
• W1945269077 hasRelatedWork W2024442761 @default.
• W1945269077 hasRelatedWork W2044633989 @default.
• W1945269077 hasRelatedWork W2066683082 @default.
• W1945269077 hasRelatedWork W2116909035 @default.
• W1945269077 hasRelatedWork W2124837587 @default.
• W1945269077 hasRelatedWork W2157570289 @default.
• W1945269077 hasRelatedWork W2162253524 @default.
• W1945269077 hasRelatedWork W2170264099 @default.
• W1945269077 hasRelatedWork W2287334810 @default.
• W1945269077 hasRelatedWork W2417532936 @default.
• W1945269077 hasRelatedWork W2556612877 @default.
• W1945269077 hasRelatedWork W2753964868 @default.
• W1945269077 isParatext "false" @default.
• W1945269077 isRetracted "false" @default.
• W1945269077 magId "1945269077" @default.
• W1945269077 workType "article" @default.